Public Profile

Zyla Life Sciences

Zyla Life Sciences, headquartered in the United States, is a prominent player in the life sciences industry, specialising in innovative healthcare solutions. Founded in recent years, the company has quickly established itself in key operational regions across North America and beyond. Zyla Life Sciences focuses on developing and commercialising unique pharmaceutical products, particularly in pain management and related therapeutic areas. Their commitment to research and development has led to the introduction of several groundbreaking treatments that stand out for their efficacy and safety profiles. With a strong market position, Zyla Life Sciences has achieved notable milestones, including strategic partnerships and a growing portfolio of proprietary products. The company continues to drive advancements in healthcare, aiming to improve patient outcomes and enhance quality of life.

DitchCarbon Score

How does Zyla Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Zyla Life Sciences's score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Zyla Life Sciences's reported carbon emissions

Zyla Life Sciences, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting its emissions. In the context of the life sciences industry, companies are increasingly recognising the importance of addressing carbon emissions and setting ambitious sustainability goals. While Zyla Life Sciences has not disclosed specific initiatives or targets, the industry trend indicates a growing emphasis on reducing Scope 1, 2, and 3 emissions to mitigate climate impact. As the company progresses, it may consider aligning with industry standards and frameworks, such as the Science Based Targets initiative (SBTi), to establish measurable and actionable climate commitments.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Zyla Life Sciences's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Zyla Life Sciences is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Zyla Life Sciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Bausch Health Cos

CA
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Assertio Holdings, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

King Pharmaceuticals LLC

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Daiichi Sankyo, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

DURECT Corporation

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers